| 1 | Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus–Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications | 3.8 | 1 | Citations (PDF) |
| 2 | Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial | 12.4 | 43 | Citations (PDF) |
| 3 | Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma | 2.6 | 20 | Citations (PDF) |
| 4 | Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma) | 12.4 | 16 | Citations (PDF) |
| 5 | Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas | 1.9 | 46 | Citations (PDF) |
| 6 | How molecular advances may improve the diagnosis and management of PTCL patients | 1.7 | 4 | Citations (PDF) |
| 7 | A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients | 2.3 | 24 | Citations (PDF) |
| 8 | Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma | 0.6 | 6 | Citations (PDF) |
| 9 | Progressive hemispheric atrophy in HIV: A Rasmussen's‐like variant of CD8 encephalitis? | 1.9 | 3 | Citations (PDF) |
| 10 | Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1Blood, 2022, 139, 2024-2037 | 3.6 | 36 | Citations (PDF) |
| 11 | Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations | 3.8 | 35 | Citations (PDF) |
| 12 | Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality | 2.7 | 16 | Citations (PDF) |
| 13 | Extranodal T- and NK-cell lymphomas | 1.9 | 36 | Citations (PDF) |
| 14 | Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 2.3 | 18 | Citations (PDF) |
| 15 | Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma | 3.7 | 65 | Citations (PDF) |
| 16 | Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation | 1.0 | 44 | Citations (PDF) |
| 17 | Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study | 1.4 | 10 | Citations (PDF) |
| 18 | Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming | 6.6 | 7 | Citations (PDF) |
| 19 | Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay | 1.9 | 32 | Citations (PDF) |
| 20 | Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma | 10.8 | 40 | Citations (PDF) |
| 21 | ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells | 2.8 | 1 | Citations (PDF) |
| 22 | Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study | 1.7 | 18 | Citations (PDF) |
| 23 | Controversies in the Treatment of Peripheral T‐cell Lymphoma | 0.6 | 8 | Citations (PDF) |
| 24 | ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells | 3.7 | 35 | Citations (PDF) |
| 25 | New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP | 3.3 | 26 | Citations (PDF) |
| 26 | EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas | 3.6 | 14 | Citations (PDF) |
| 27 | Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma | 12.4 | 88 | Citations (PDF) |
| 28 | High total metabolic tumor volume at baseline predicts survival independent of response to therapyBlood, 2020, 135, 1396-1405 | 3.6 | 176 | Citations (PDF) |
| 29 | Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial | 3.7 | 87 | Citations (PDF) |
| 30 | Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma | 4.1 | 49 | Citations (PDF) |
| 31 | Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. | 3.6 | 84 | Citations (PDF) |
| 32 | Anaplastic large cell lymphomas associated with breast implants: from diagnosis to molecular sequencing | 0.0 | 0 | Citations (PDF) |
| 33 | Complete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemia | 1.0 | 0 | Citations (PDF) |
| 34 | GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism | 28.4 | 52 | Citations (PDF) |
| 35 | Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistryBlood, 2019, 134, 2159-2170 | 3.6 | 170 | Citations (PDF) |
| 36 | Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas | 3.7 | 141 | Citations (PDF) |
| 37 | Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma | 1.5 | 30 | Citations (PDF) |
| 38 | The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 mutations | 3.8 | 71 | Citations (PDF) |
| 39 | Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaBlood, 2019, 133, 1664-1676 | 3.6 | 255 | Citations (PDF) |
| 40 | Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activationBlood, 2018, 131, 2036-2046 | 3.6 | 60 | Citations (PDF) |
| 41 | Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies | 2.0 | 14 | Citations (PDF) |
| 42 | Definition of a minimal genes set for mature lymphoid blood diseases | 0.0 | 4 | Citations (PDF) |
| 43 | Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphomaBlood, 2018, 132, 2305-2309 | 3.6 | 171 | Citations (PDF) |
| 44 | New insights into breast implant-associated anaplastic large cell lymphoma | 1.3 | 32 | Citations (PDF) |
| 45 | Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing | 1.9 | 27 | Citations (PDF) |
| 46 | New insights in the pathogenesis of T-cell lymphomas | 1.3 | 34 | Citations (PDF) |
| 47 | Relecture centralisée du diagnostic histopathologique de lymphome. Résultats et perspectives d’une étude nationale à grande échelle | 0.0 | 0 | Citations (PDF) |
| 48 | The Genetic Basis of Hepatosplenic T-cell Lymphoma | 6.8 | 195 | Citations (PDF) |
| 49 | Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas | 2.3 | 27 | Citations (PDF) |
| 50 | Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study | 2.8 | 21 | Citations (PDF) |
| 51 | Du neuf dans l’oncogenèse moléculaire des lymphomes : rôle du gèneSETD2dans les lymphomes T de l’intestin | 0.2 | 2 | Citations (PDF) |
| 52 | Expert central review in lymphoma diagnosis. Is there a need? | 0.5 | 1 | Citations (PDF) |
| 53 | Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma | 5.2 | 100 | Citations (PDF) |
| 54 | The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development | 5.2 | 121 | Citations (PDF) |
| 55 | Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma | 2.8 | 19 | Citations (PDF) |
| 56 | CD1d-restricted peripheral T cell lymphoma in mice and humans | 5.9 | 24 | Citations (PDF) |
| 57 | ALK-negative anaplastic large-cell lymphomaBlood, 2016, 127, 175-177 | 3.6 | 9 | Citations (PDF) |
| 58 | Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomasBlood, 2016, 128, 1490-1502 | 3.6 | 307 | Citations (PDF) |
| 59 | Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations | 10.8 | 175 | Citations (PDF) |
| 60 | Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3−/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic | 3.8 | 44 | Citations (PDF) |
| 61 | Idh1
mutations contribute to the development of T-cell malignancies in genetically engineered mice | 5.2 | 23 | Citations (PDF) |
| 62 | Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell LymphomasBlood, 2016, 128, 4164-4164 | 3.6 | 31 | Citations (PDF) |
| 63 | First Analysis of an International Double-Blind Randomized Phase III Study of Lenalidomide Maintenance in Elderly Patients with DLBCL Treated with R-CHOP in First Line, the Remarc Study from LysaBlood, 2016, 128, 471-471 | 3.6 | 13 | Citations (PDF) |
| 64 | Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS CategoryBlood, 2016, 128, 2932-2932 | 3.6 | 0 | Citations (PDF) |
| 65 | Clinical Spectrum, Evolution and Management of Autoimmune Cytopenia Associated with Angioimmunoblastic T-Cell Lymphoma: A Retrospective, Multicenter StudyBlood, 2016, 128, 1816-1816 | 3.6 | 1 | Citations (PDF) |
| 66 | Incidence and Risk Factors for Central Nervous System Relapse in Very Elderly Patients over 80 with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Two Lysa StudiesBlood, 2016, 128, 927-927 | 3.6 | 0 | Citations (PDF) |
| 67 | MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA studyBlood, 2015, 126, 2466-2474 | 3.6 | 245 | Citations (PDF) |
| 68 | Aspects moléculaires des lymphomes T périphériques (2) | 0.2 | 1 | Citations (PDF) |
| 69 | Aspects moléculaires des lymphomes T périphériques (1) | 0.2 | 3 | Citations (PDF) |
| 70 | Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells | 10.8 | 389 | Citations (PDF) |
| 71 | Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma | 4.5 | 100 | Citations (PDF) |
| 72 | Follicular variant of peripheral T cell lymphoma with mediastinal involvement in a child: a case report | 1.9 | 5 | Citations (PDF) |
| 73 | Mature T-cell lymphomas | 0.4 | 2 | Citations (PDF) |
| 74 | Number of Circulating t(14;18) Tumor Cells at Diagnosis Is Related to, but Add to the Prognostic Value of Metabolic Tumor Burden in Follicular LymphomaBlood, 2015, 126, 3872-3872 | 3.6 | 0 | Citations (PDF) |
| 75 | Peripheral T-cell lymphomas | 0.0 | 0 | Citations (PDF) |
| 76 | Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5‐Azacytidine | 1.5 | 56 | Citations (PDF) |
| 77 | Pathology of Peripheral T-Cell Lymphomas: Where Do We Stand? | 2.3 | 51 | Citations (PDF) |
| 78 | The microenvironment in T-cell lymphomas: Emerging themes | 10.5 | 62 | Citations (PDF) |
| 79 | Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology | 2.6 | 160 | Citations (PDF) |
| 80 | Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma | 14.1 | 199 | Citations (PDF) |
| 81 | Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaBlood, 2014, 123, 2915-2923 | 3.6 | 520 | Citations (PDF) |
| 82 | Cellular origin of T-cell lymphomasBlood, 2014, 123, 2909-2910 | 3.6 | 25 | Citations (PDF) |
| 83 | Molecular underpinning of extranodal NK/T-cell lymphoma | 1.6 | 67 | Citations (PDF) |
| 84 | HACE1 Is a Tumor Suppressor Gene Candidate in Natural Killer Cell Neoplasms | 2.8 | 56 | Citations (PDF) |
| 85 | Peripheral T‐cell lymphoma in HIV‐infected patients: a study of 17 cases in the combination antiretroviral therapy era | 1.7 | 9 | Citations (PDF) |
| 86 | VIII. New markers in peripheral T‐cell lymphomas: more entities or more confusion? | 1.6 | 2 | Citations (PDF) |
| 87 | Indolent T-cell lymphoproliferative disease of the gastrointestinal tractBlood, 2013, 122, 3599-3606 | 3.6 | 192 | Citations (PDF) |
| 88 | ROQUIN/RC3H1 Alterations Are Not Found in Angioimmunoblastic T-Cell Lymphoma | 1.5 | 15 | Citations (PDF) |
| 89 | Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials | 12.4 | 185 | Citations (PDF) |
| 90 | Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics | 2.3 | 89 | Citations (PDF) |
| 91 | Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in miceBlood, 2012, 120, 812-821 | 3.6 | 44 | Citations (PDF) |
| 92 | Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targetsBlood, 2012, 119, 5795-5806 | 3.6 | 107 | Citations (PDF) |
| 93 | Early lesions in lymphoid neoplasia | 0.3 | 33 | Citations (PDF) |
| 94 | MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantationBlood, 2012, 119, 4619-4624 | 3.6 | 153 | Citations (PDF) |
| 95 | Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphomaBlood, 2012, 120, 3997-4005 | 3.6 | 72 | Citations (PDF) |
| 96 | New biomarkers in T-cell lymphomas | 1.6 | 21 | Citations (PDF) |
| 97 | Epidermotropic secondary cutaneous involvement by relapsed angioimmunoblastic T‐cell lymphoma mimicking mycosis fungoides: a case report | 0.7 | 16 | Citations (PDF) |
| 98 | Ten-Year Relative Survival and Causes of Death in Elderly Patients Treated With R-CHOP or CHOP in the GELA LNH-985 Trial | 0.8 | 19 | Citations (PDF) |
| 99 | Pièges et nouveautés en hématopathologie. Introduction et résumé des principaux messages | 0.1 | 1 | Citations (PDF) |
| 100 | Pièges et nouveautés en hématopathologie. Conclusion | 0.1 | 1 | Citations (PDF) |
| 101 | Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western EuropeBlood, 2012, 120, 1607-1607 | 3.6 | 3 | Citations (PDF) |
| 102 | Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial | 16.1 | 528 | Citations (PDF) |
| 103 | Follicular helper T cells: implications in neoplastic hematopathology | 1.8 | 97 | Citations (PDF) |
| 104 | Tricky and Terrible T-Cell Tumors: These are Thrilling Times for Testing: Molecular Pathology of Peripheral T-Cell Lymphomas | 1.9 | 13 | Citations (PDF) |
| 105 | Nonhepatosplenic γδ T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation | 2.3 | 125 | Citations (PDF) |
| 106 | Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyBlood, 2011, 117, 1834-1839 | 3.6 | 376 | Citations (PDF) |
| 107 | Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker ConsortiumBlood, 2011, 117, 7070-7078 | 3.6 | 182 | Citations (PDF) |
| 108 | Pathology and biology of peripheral T-cell lymphomas | 2.6 | 51 | Citations (PDF) |
| 109 | Extranodal NK/T‐Cell Lymphoma: Toward the Identification of Clinical Molecular Targets | 2.3 | 20 | Citations (PDF) |
| 110 | Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeBlood, 2010, 115, 1226-1237 | 3.6 | 308 | Citations (PDF) |
| 111 | Hepatosplenic T cell lymphoma responsive to 2′‐deoxycoformycin therapy | 5.2 | 17 | Citations (PDF) |
| 112 | Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma | 1.7 | 235 | Citations (PDF) |
| 113 | Multifocal polyclonal Epstein–Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab | 1.0 | 4 | Citations (PDF) |
| 114 | Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma | 2.8 | 30 | Citations (PDF) |
| 115 | Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up | 1.0 | 46 | Citations (PDF) |
| 116 | Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors | 5.2 | 97 | Citations (PDF) |
| 117 | The mechanisms underlying MMR deficiency in immunodeficiency‐related non‐Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms | 2.8 | 17 | Citations (PDF) |
| 118 | Molecular classification of T-cell lymphomas | 3.5 | 70 | Citations (PDF) |
| 119 | Lymphome T gamma-delta : complication possible d’une splénomégalie palustre hyperactive ? | 0.1 | 0 | Citations (PDF) |
| 120 | Nodal follicular helper T-cell lymphoma may present with different patterns. A case report | 1.7 | 15 | Citations (PDF) |
| 121 | Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion | 1.7 | 16 | Citations (PDF) |
| 122 | Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis | 1.0 | 4 | Citations (PDF) |
| 123 | Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas | 2.3 | 206 | Citations (PDF) |
| 124 | Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphomaBlood, 2009, 114, 1236-1242 | 3.6 | 123 | Citations (PDF) |
| 125 | Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas | 1.9 | 30 | Citations (PDF) |
| 126 | STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-Cell lymphoma | 3.7 | 48 | Citations (PDF) |
| 127 | CD3-T cell receptor modulation is selectively induced in CD8 but not CD4 lymphocytes cultured in agar | 2.3 | 0 | Citations (PDF) |
| 128 | Hodgkin Lymphoma–Associated Hemophagocytic Syndrome: A Disorder Strongly Correlated with Epstein‐Barr Virus | 3.7 | 72 | Citations (PDF) |
| 129 | Primary Hepatic Lymphoma of Mucosa-Associated Lymphoid Tissue Type: A Case Report With Cytogenetic Study | 0.6 | 17 | Citations (PDF) |
| 130 | Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsBlood, 2008, 111, 4463-4470 | 3.6 | 333 | Citations (PDF) |
| 131 | Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate | 4.0 | 66 | Citations (PDF) |
| 132 | Hepatosplenic and Other γΔ T-Cell Lymphomas | 0.4 | 142 | Citations (PDF) |
| 133 | Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium | 12.4 | 277 | Citations (PDF) |
| 134 | Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypesBlood, 2007, 109, 2156-2164 | 3.6 | 188 | Citations (PDF) |
| 135 | Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsBlood, 2007, 109, 2183-2189 | 3.6 | 64 | Citations (PDF) |
| 136 | The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cellsBlood, 2007, 109, 4952-4963 | 3.6 | 590 | Citations (PDF) |
| 137 | Characterization of CXCL13+ Neoplastic T Cells in Cutaneous Lesions of Angioimmunoblastic T-cell Lymphoma (AITL) | 2.3 | 62 | Citations (PDF) |
| 138 | Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression | 2.3 | 211 | Citations (PDF) |
| 139 | Intérêt des Tumorothèques pour la recherche et le diagnostic des lymphomes | 0.1 | 0 | Citations (PDF) |
| 140 | Involvement of STAT3 Transcription Factor in Disseminated Nasal-Type Natural Killer Cell Lymphomas.Blood, 2007, 110, 4167-4167 | 3.6 | 0 | Citations (PDF) |
| 141 | Lymphomes B diffus à grandes cellules : de la morphologie à la biologie | 0.1 | 2 | Citations (PDF) |
| 142 | Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL) | 2.3 | 229 | Citations (PDF) |
| 143 | Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology | 5.2 | 20 | Citations (PDF) |
| 144 | Mediastinal Gray Zone Lymphoma | 2.3 | 325 | Citations (PDF) |
| 145 | Sarcomatoid Variant of Anaplastic Large Cell Lymphoma Mimics ALK-1-Positive Inflammatory Myofibroblastic Tumor in Bladder | 2.3 | 16 | Citations (PDF) |
| 146 | [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcomeBlood, 2005, 106, 1376-1381 | 3.6 | 486 | Citations (PDF) |
| 147 | Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement | 1.9 | 28 | Citations (PDF) |
| 148 | Une tumeur sous-cutanée chez un jeune homme | 0.1 | 0 | Citations (PDF) |
| 149 | Epstein-Barr virus–associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: A case of spontaneous regression | 1.5 | 21 | Citations (PDF) |
| 150 | Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patientsBlood, 2004, 103, 1222-1228 | 3.6 | 146 | Citations (PDF) |
| 151 | The mutator pathway is a feature of immunodeficiency-related lymphomas | 5.2 | 71 | Citations (PDF) |
| 152 | FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP) | 3.7 | 11 | Citations (PDF) |
| 153 | TiA1 in advanced-stage classical Hodgkin?s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells | 1.9 | 9 | Citations (PDF) |
| 154 | CD10 expression in diffuse large B-cell lymphomas does not influence survival | 1.9 | 33 | Citations (PDF) |
| 155 | Maladie de Hodgkin classique : biologie et formes frontières | 0.1 | 3 | Citations (PDF) |
| 156 | Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosisBlood, 2004, 103, 2727-2737 | 3.6 | 129 | Citations (PDF) |
| 157 | Constitutive STAT6 activation in primary mediastinal large B-cell lymphomaBlood, 2004, 104, 543-549 | 3.6 | 197 | Citations (PDF) |
| 158 | In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study | 1.9 | 28 | Citations (PDF) |
| 159 | Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma | 5.9 | 1,059 | Citations (PDF) |
| 160 | Primary lymphoma of the liver: Clinical-pathological features and relationship with HCV infection in French patients | 9.6 | 140 | Citations (PDF) |
| 161 | γδT-cell lymphomas | 2.3 | 67 | Citations (PDF) |
| 162 | Maladie de Kikuchi récidivante chez une patiente atteinte de lupus discoïde | 0.1 | 11 | Citations (PDF) |
| 163 | Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Blood, 2003, 101, 4279-4284 | 3.6 | 488 | Citations (PDF) |
| 164 | Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma | 3.6 | 4 | Citations (PDF) |
| 165 | Pathobiology of Primary Mediastinal B-Cell Lymphoma | 1.0 | 62 | Citations (PDF) |
| 166 | Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsBlood, 2003, 102, 4261-4269 | 3.6 | 454 | Citations (PDF) |
| 167 | MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell Lymphomas | 3.8 | 144 | Citations (PDF) |
| 168 | CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma | 26.5 | 5,430 | Citations (PDF) |
| 169 | Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome | 0.7 | 104 | Citations (PDF) |
| 170 | Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression | 1.7 | 103 | Citations (PDF) |
| 171 | Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein–Barr virus infection. A different subtype of AILD-TL? | 3.7 | 49 | Citations (PDF) |
| 172 | Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics | 3.7 | 85 | Citations (PDF) |
| 173 | A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response | 14.1 | 308 | Citations (PDF) |
| 174 | Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome | 0.7 | 0 | Citations (PDF) |
| 175 | Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations | 1.7 | 35 | Citations (PDF) |
| 176 | T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell–cell contacts | 2.8 | 99 | Citations (PDF) |
| 177 | Pathologic and Clinical Features of 77 Hodgkin's Lymphoma Patients Treated in a Lymphoma Protocol (LNH87) | 2.3 | 37 | Citations (PDF) |
| 178 | Bone Marrow Involvement in Lymphomas With Hemophagocytic Syndrome at Presentation | 2.3 | 76 | Citations (PDF) |
| 179 | ALK is not expressed in Hodgkin diseaseBlood, 2001, 97, 1901-1902 | 3.6 | 14 | Citations (PDF) |
| 180 | Erythroblasts are a source of angiogenic factorsBlood, 2001, 97, 1968-1974 | 3.6 | 103 | Citations (PDF) |
| 181 | Virus epstein-barr et lymphomes T/NK : intérêt physiopathologique et pratique | 0.0 | 1 | Citations (PDF) |
| 182 | Survival and Clonal Expansion of Mutating “Forbidden” (Immunoglobulin Receptor–Deficient) Epstein-Barr Virus–Infected B Cells in Angioimmunoblastic T Cell Lymphoma | 5.9 | 109 | Citations (PDF) |
| 183 | Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma | 0.6 | 10 | Citations (PDF) |
| 184 | Association of Primary Pleural Effusion Lymphoma of T-Cell Origin and Human Herpesvirus 8 in a Human Immunodeficiency Virus–Seronegative Man | 1.7 | 47 | Citations (PDF) |
| 185 | Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study | 12.4 | 403 | Citations (PDF) |
| 186 | UNUSUAL PERIPHERAL T CELL LYMPHOMA PRESENTING AS ACUTE LIVER FAILURE AND REAPPEARING IN THE LIVER ALLOGRAFT | 1.4 | 24 | Citations (PDF) |
| 187 | Hepatosplenic αβ T-Cell Lymphoma | 2.3 | 91 | Citations (PDF) |
| 188 | Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins | 2.6 | 82 | Citations (PDF) |
| 189 | De novo acute B cell leukemia/lymphoma with t(14;18) | 3.7 | 43 | Citations (PDF) |
| 190 | Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLTspecific probesBlood, 2000, 96, 2215-2218 | 3.6 | 96 | Citations (PDF) |
| 191 | Expression of Cytotoxic Proteins in Peripheral T-Cell and Natural Killer-Cell (NK) Lymphomas: Association with Extranodal Site, NK or Tγδ Phenotype, Anaplastic Morphology and CD30 Expression | 1.0 | 54 | Citations (PDF) |
| 192 | Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation | 9.6 | 73 | Citations (PDF) |
| 193 | Increased expression of interleukin-4 during liver allograft rejection | 6.7 | 29 | Citations (PDF) |
| 194 | Primary Brain Lymphoma Cell Turnover Differs in Patients With and Without AIDS: Relationships to bcl-2 Expression and Host Cell Reaction | 1.4 | 6 | Citations (PDF) |
| 195 | Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas | 5.2 | 40 | Citations (PDF) |
| 196 | Lymphomes non hodgkiniens. Aspects anatomocliniques | 0.1 | 3 | Citations (PDF) |
| 197 | Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas | 2.8 | 78 | Citations (PDF) |
| 198 | Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and OutcomeBlood, 1997, 90, 3727-3734 | 3.6 | 162 | Citations (PDF) |
| 199 | Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases | 0.7 | 31 | Citations (PDF) |
| 200 | Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T-cell lymphomas | 3.2 | 88 | Citations (PDF) |
| 201 | Nasopharyngeal lymphomas: Further evidence for a natural killer cell origin | 1.7 | 32 | Citations (PDF) |
| 202 | Darier's sign in cutaneous large T-cell lymphoma | 1.5 | 6 | Citations (PDF) |
| 203 | EPSTEIN-BARR VIRUS IN NON-HODGKIN'S LYMPHOMAS OF THE UPPER RESPIRATORY TRACT: ASSOCIATION WITH SINONASAL LOCALIZATION AND EXPRESSION OF NK AND/OR T-CELL ANTIGENS BY TUMOUR CELLS | 3.2 | 34 | Citations (PDF) |
| 204 | VJ REARRANGEMENTS OF THE TCRγ LOCUS IN PERIPHERAL T-CELL LYMPHOMAS: ANALYSIS BY POLYMERASE CHAIN REACTION AND DENATURING GRADIENT GEL ELECTROPHORESIS 1996, 178, 303-310 | | 95 | Citations (PDF) |
| 205 | CD56 Lymphomas | 2.3 | 0 | Citations (PDF) |
| 206 | Definitive Diagnosis with the Use of Monoclonal Antibody O10 on Routinely Paraffin-embedded Samples | 2.3 | 159 | Citations (PDF) |
| 207 | Carpal tunnel syndrome due to t cell lymphoma | 6.1 | 17 | Citations (PDF) |
| 208 | Epstein-Barr Virus (EBV) in Extranodal T-cell Non-Hodgkin's Lymphomas (T-NHL). Identification of Nasal T-NHL as a Distinct Clinicopathological Entity Associated with EBV | 1.0 | 36 | Citations (PDF) |
| 209 | Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand | 1.1 | 183 | Citations (PDF) |
| 210 | Recombination pattern of the TCR γ locus in human peripheral T-cell lymphomas | 3.2 | 72 | Citations (PDF) |
| 211 | Bilateral tumoral infiltration of the achilles tendons revealing chronic myelomonocytic leukemia | 6.1 | 9 | Citations (PDF) |
| 212 | Systemic mastocytosis following mediastinal germ cell tumor: An association confirmed | 1.7 | 23 | Citations (PDF) |
| 213 | Epstein-Barr Virus (EBV) Genomes and EBV-Encoded Latent Membrane Protein (LMP) in Pulmonary Lymphomas Occurring in Nonimmunocompromised Patients | 2.3 | 38 | Citations (PDF) |
| 214 | Primary lymphoma of the liver | 0.0 | 44 | Citations (PDF) |
| 215 | Clinical and Biological Analysis of Peripheral T-Cell Lymphomas: A Single Institution Study | 1.0 | 20 | Citations (PDF) |
| 216 | Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence. | 1.3 | 62 | Citations (PDF) |
| 217 | Intraepidermal localization of the clone in cutaneous T-cell lymphoma | 1.5 | 49 | Citations (PDF) |
| 218 | Bone marrow histologic and immunohistochemical findings in peripheral T-cell lymphoma: A study of 38 cases | 1.7 | 64 | Citations (PDF) |
| 219 | Applications de l'immunohistochimie à la pathologie lymphoïde | 0.1 | 2 | Citations (PDF) |
| 220 | Interleukin-2 and Interferon-gamma Production in Follicular Lymphomas | 0.4 | 28 | Citations (PDF) |
| 221 | Percutaneous Fine Needle Aspiration Cytology and Biopsy in the Diagnosis and Classification of Lymphoma: Clinical Evaluation | 1.0 | 2 | Citations (PDF) |
| 222 | Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas. | 6.6 | 37 | Citations (PDF) |
| 223 | 273 THE SPECTRUM OF MUSCLE AND NERVE VASCULITIS IN AIDS | 1.4 | 0 | Citations (PDF) |
| 224 | Polymerase chain reaction (PCR) amplification demonstrates the absence of human T-cell lymphotrophic virus (HTLV)-I specific pol sequences in peripheral T-cell lymphomas | 1.7 | 1 | Citations (PDF) |
| 225 | Lymphomatoid granulomatosis in a patient with acute myeloblastic leukemia in remission | 2.7 | 28 | Citations (PDF) |
| 226 | Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. | 1.3 | 82 | Citations (PDF) |
| 227 | Mediastinal Diffuse Large-Cell Lymphoma with Sclerosis | 1.1 | 57 | Citations (PDF) |
| 228 | Necrotizing Vasculitis and HIV Replication in Peripheral Nerves | 26.5 | 93 | Citations (PDF) |
| 229 | PATHOLOGY OF MUSCLE IN TRICHINOSIS | 1.4 | 1 | Citations (PDF) |
| 230 | Presence of HTLV-I proviral DNA in patients with adult T-Cell leukemia/lymphoma in Taiwan | 2.7 | 136 | Citations (PDF) |
| 231 | Failure of Combination Chemotherapy of Advanced Follicular (Low-Grade) Non-Hodgkinʼs Lymphoma | 1.1 | 2 | Citations (PDF) |
| 232 | Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma | 1.4 | 77 | Citations (PDF) |
| 233 | Peripheral neuropathy with distal nerve infiltration revealing a diffuse pleiomorphic malignant lymphoma | 2.7 | 34 | Citations (PDF) |
| 234 | Leucoencephalopathy with multinucleated giant cells containing human immune deficiency virus-like particles and multiple opportunistic cerebral infections in one patient with AIDS | 5.8 | 26 | Citations (PDF) |
| 235 | T-Cell lymphoma revealed by a peripheral neuropathy: A report of two cases with an immunohistologic study on lymph node and nerve biopsies | 2.7 | 77 | Citations (PDF) |
| 236 | Can peripheral T-Cell lymphomas be morphologically subclassified? A morphometric approach to 21 cases | 0.0 | 8 | Citations (PDF) |
| 237 | Peripheral T-cell lymphoma presenting as predominant liver disease: A report of three cases | 9.6 | 79 | Citations (PDF) |
| 238 | Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study | 3.7 | 5 | Citations (PDF) |
| 239 | Lymphome du manteau blastoïde TdT+ : vers un profil plus juvénile ? | 0.1 | 0 | Citations (PDF) |
| 240 | Approche diagnostique des lymphomes T non cutanés en 2025 : quels écueils et comment classer ? | 0.1 | 0 | Citations (PDF) |
